Medexus Pharmaceuticals (OTCMKTS:MEDXF) Stock In Focus After New Appointments
A company that may well be on the radars of investors this morning is Medexus Pharmaceuticals (OTCMKTS:MEDXF) owing to the announcement it made on Monday. The company announced yesterday that it welcomed MenassieTaddese and Harmony P Garges into its board of directors.
Trading Data
On Monday, MEDXF stock slid 2.86% to $1.3600 with 1K shares, compared to volume of 16.78K shares. The stock moved within a range of $1.3600 – 1.3672 after opening trade at $1.3672.
Medexus Welcomes Two New Board Members
The addition of new members to the board of directors is almost always a significant event and it may be a good idea to take a closer look into the credentials of the two individuals. Taddese is a former executive of pharmaceutical giant Pfizer and Viatris, while Garges is currently the Chief Medical Officer of ViiV Healthcare.
The Chair of the Compensation, Corporate Governance, and Nominating Committee at the company’s board Benoit Gravel spoke about the latest appointments as well. He noted that everyone at the company was pleased to have been able to welcome both Taddese and Garges to the board.
He noted that the skills of the two experienced professionals and their expertise would only in diversifying the skills sets of the members of the Medexus board. However, it is now going to be interesting to see if there is any immediate impact on the company’s stock following this major development.
